$ABPI ACCENTIA BIOPHARMACEUTICALS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCENTIA BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in ACCENTIA BIOPHARMACEUTICALS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
ACCENTIA BIOPHARMACEUTICALS INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ACCENTIA BIOPHARMACEUTICALS INC | 10% Owner | 85,756,855 | 0 | Aug 31 2012 | |||
| ACCENTIA BIOPHARMACEUTICALS INC | 80,962,482 | 0 | Feb 22 2013 | ||||
| ARIKIAN STEVEN | Pres, COO, Biopharmaceutical P | 950,544 | 0 | Nov 04 2005 | |||
| ARIKIAN STEVEN | See General Remarks | 0 | 0 | Mar 04 2008 | |||
| BAUM MARTIN | Pres, COO, Specialty Pharmaceu | 329,399 | 0 | Nov 04 2005 | |||
| Calder Douglas W | VP Strategic Plan/Cap Markets | 0 | 0 | Sep 14 2012 | |||
| CHAPMAN CHRISTOPHER C | Director | 0 | 0 | Mar 02 2012 | |||
| DUBINSKY JOHN P | Director | 0 | 0 | Nov 04 2005 | |||
| DUBINSKY JOHN P | Director | 143,394 | 0 | Mar 04 2008 | |||
| DUFFEY SAMUEL S | CEO/PRESIDENT/GENERAL COUNSEL | 0 | 0 | Sep 14 2012 | |||
| Hasara Garrison J. | Acting Chief Financial Officer | 0 | 0 | Sep 14 2012 | |||
| HOLMAN C RAY | Director | 43,750 | 0 | Nov 04 2005 | |||
| HOPKINS CAPITAL GROUP LLC | 10% Owner | 4,381,659 | 0 | Nov 04 2005 | |||
| HOPKINS CAPITAL GROUP LLC | 10% Owner | 4,385,992 | 0 | Jun 23 2006 | |||
| KING EDMUND | Director | 0 | 0 | Mar 04 2008 | |||
| KING EDMUND | Director | 0 | 0 | Mar 02 2012 | |||
| MOAB INVESTMENT LP | 10% Owner | 3,628,821 | 0 | Nov 04 2005 | |||
| MOAB INVESTMENT LP | 10% Owner | 412,892 | 0 | May 18 2006 | |||
| MOAB INVESTMENT LP | 10% Owner | 0 | 0 | Jun 19 2007 | |||
| ODONNELL FRANCIS E JR | Chief Executive Officer | 4,360,992 | 0 | Aug 13 2008 | |||
| ODONNELL FRANCIS E JR | Chief Executive Officer | 4,381,659 | 0 | Nov 04 2005 | |||
| ODONNELL FRANCIS E JR | Chief Executive Officer | 412,892 | 0 | May 18 2006 | |||
| ODONNELL FRANCIS E JR | EXECUTIVE CHAIRMAN | 1,960,992 | 0 | Nov 12 2013 | |||
| Pearce Alan M | Chief Financial Officer | 1,260,403 | 0 | Jan 12 2011 | |||
| PEARCE ALLAN | Chief Financial Officer | 648,768 | 0 | Nov 04 2005 | |||
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 10% Owner | 4,270,323 | 0 | Nov 04 2005 | |||
| Poole William | Director | 0 | 0 | Mar 02 2012 | |||
| RYLL DENNIS L | Director | 3,628,821 | 0 | Nov 04 2005 | |||
| RYLL DENNIS L | Director | 3,634,160 | 0 | Jun 23 2006 | |||
| RYLL TIMOTHY D | 10% Owner | 3,634,160 | 0 | Jun 23 2006 | |||
| RYLL TIMOTHY D | 10% Owner | 0 | 0 | Jun 19 2007 | |||
| Santos Carlos | Sr. VP of Prod Dev/Reg Affairs | 0 | 0 | Sep 14 2012 | |||
| SCHUBERT DAVID M | Director | 0 | 0 | Oct 31 2005 | |||
| SCHUBERT DAVID M | Director | 0 | 0 | Mar 02 2012 | |||
| STOGEL STEVEN J | Director | 434,243 | 0 | Jun 23 2006 | |||
| THOMASON TODD D | Director | 0 | 0 | Nov 03 2006 |